Financial News
Marinus Pharma CS (NQ: MRNS )
1.300
-0.020
(-1.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Marinus Pharma CS
![](https://cdn.benzinga.com/files/images/story/2024/04/15/image20.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
April 15, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/10/wall-street-bull.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/15/crude_oil_6-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2024/03/dwac-truth-social1600.png)
![](https://investorplace.com/wp-content/uploads/2020/02/medicine-iv-drip.jpg)
![](https://ml.globenewswire.com/media/60f84371-8ef5-454a-ab60-63e56a837741/small/schall-firm-logo-2-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Marinus Pharma's Earnings Outlook
March 04, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/04/15/MRNS.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/15/image31_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/15/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 15, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240415026329/en/1638593/5/marinus-color.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Analyst Expectations for Marinus Pharma's Future
December 05, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20240405633110/en/2090706/5/marinus-color-R.jpg)
![](https://mms.businesswire.com/media/20240327247358/en/1638593/5/marinus-color.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240305071461/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20240221704060/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
February 21, 2024
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240220631175/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20240216567771/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20240104557883/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20240104049645/en/1638593/5/marinus-color.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.